Abstract
We determined the acyclovir (ACV) susceptibilities of herpes simplex virus (HSV) isolates (n = 18) recovered from solid organ transplant patients after antiviral prophylaxis with ACV or ganciclovir. All isolates tested were susceptible to ACV (50% inhibitory concentration, <1 μM). A clinical review of patients with HSV disease showed that all improved with specific anti-HSV therapy, and no recurrences were reported.
Original language | English (US) |
---|---|
Pages (from-to) | 357-359 |
Number of pages | 3 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 37 |
Issue number | 2 |
DOIs |
|
State | Published - 1993 |